J Korean Surg Soc.  2005 Sep;69(3):210-216.

C-met and E-cadherin Expression in Advanced Gastric Cancer

Affiliations
  • 1Department of Surgery, Gachon Medical School, Gil Medical Center, Incheon, Korea. www.lwk@gilhospital.com
  • 2Department of Molecular Biology, Gachon Medical School, Gil Medical Center, Incheon, Korea.
  • 3ChangMon Clinic, Gachon Medical School, Gil Medical Center, Incheon, Korea.

Abstract

PURPOSE
In the current study, the relation between the clinicopathological parameters and levels of the amplification of the c-met and E-cadherin genes were investigated in patients with an advanced gastric carcinoma. METHODS: The levels of amplification of the c-met and E-cadherin genes in 44 advanced gastric carcinoma patients were retrospectively investigated using RT-PCR. The relationships between the levels of amplification of these genes and the clinicopathological parameters were evaluated using univariate and multivariate analyses. RESULTS: Seventeen (38.6%) and 13 (29.5%) of the 44 advanced gastric carcinoma patients were evaluated as having amplification of the c-met gene and down-regulation of the E-cadherin gene, respectivly. The amplification of c- met gene was significantly correlated with serosal invasion, lymph node metastasis and neural invasion, whereas the down-regulation of the E-cadherin gene was significantly correlated with the diffuse type of gastric carcinoma by Lauren's calssification, and neural invasion. CONCLUSION: The levels of the c-met and E-cadherin gene amplifications may be a powerful aids in evaluating the metastatic potential and prognosis in patients with advanced gastric cancer.

Keyword

Advanced gastric cancer; C-met; E-cadherin; Clinicopathological parameters

MeSH Terms

Cadherins*
Down-Regulation
Humans
Lymph Nodes
Multivariate Analysis
Neoplasm Metastasis
Prognosis
Retrospective Studies
Stomach Neoplasms*
Cadherins
Full Text Links
  • JKSS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr